• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.

作者信息

Lawrence D A, Strandberg L, Ericson J, Ny T

机构信息

Department of Applied Cell and Molecular Biology, University of Umeå, Sweden.

出版信息

J Biol Chem. 1990 Nov 25;265(33):20293-301.

PMID:1700786
Abstract

Three chimeric mutants of plasminogen activator inhibitor 1 (PAI-1) have been constructed where the strained loop of wild type PAI-1 (wtPAI-1) has been replaced with a 19-amino acid region from either plasminogen activator inhibitor 2 (PAI-2), antithrombin III, or with an artificial serine protease inhibitor superfamily consensus strained loop. The inhibitors were expressed in Escherichia coli, and the purified proteins had specific activities toward urokinase-type plasminogen activator (uPA) or the single- and two-chain forms of tissue type plasminogen activator (tPA) that were similar to wtPAI-1. Experiments suggest that the strained loop of PAI-1 is not responsible for the transition between the latent and the active conformations or for binding to vitronectin. Second-order rate constants for the interactions with uPA and single- or two-chain tPA were similar to those of wtPAI-1. Values range from a low of 1.8 x 10(5) M-1 s-1 for the interaction of the PAI-2 chimera with single-chain tPA to a high value of 1.6 x 10(7) M-1 s-1 for the consensus mutant with two-chain tPA. This former value is 200 times higher than the reported rate constant for the interaction between PAI-2 and single-chain tPA, suggesting that structures outside of the strained loop are responsible for the major differences in specificity between PAI-1 and PAI-2.

摘要

相似文献

1
Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.
J Biol Chem. 1990 Nov 25;265(33):20293-301.
2
Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.蛋白质辅因子对丝氨酸蛋白酶抑制剂特异性的改变。纤连蛋白赋予纤溶酶原激活物抑制剂1凝血酶抑制特性。
J Biol Chem. 1990 Aug 5;265(22):13029-35.
3
Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.构建具有更高功能稳定性的纤溶酶原激活物抑制剂1突变体。
Biochemistry. 1994 Mar 29;33(12):3643-8. doi: 10.1021/bi00178a022.
4
Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Eur J Biochem. 1989 Dec 22;186(3):523-33. doi: 10.1111/j.1432-1033.1989.tb15238.x.
5
Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.2型纤溶酶原激活物抑制剂(PAI-2)是一种可自发聚合的丝氨酸蛋白酶抑制剂。重组细胞内和细胞外形式的生化特性。
Eur J Biochem. 1993 Dec 15;218(3):1071-82. doi: 10.1111/j.1432-1033.1993.tb18467.x.
6
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center.纤溶酶原激活物抑制剂-1反应中心的饱和诱变
J Biol Chem. 1992 Apr 15;267(11):7588-95.
7
Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.纤溶酶原激活物抑制剂-1的远端铰链区涉及其潜伏态转变以及对丝氨酸蛋白酶的特异性。
BMC Biochem. 2003 Jul 8;4:5. doi: 10.1186/1471-2091-4-5.
8
Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.玻连蛋白调控纤溶酶原激活物抑制剂1与组织型纤溶酶原激活物之间的相互作用。
J Biol Chem. 1991 Jun 5;266(16):10700-7.
9
Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.纤溶酶原激活物抑制剂-1的底物行为与反应位点环插入缺失无关。
Biochemistry. 1996 Jun 11;35(23):7474-81. doi: 10.1021/bi960079d.
10
Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop.通过活性位点环中的点突变将纤溶酶原激活物抑制剂-1从抑制剂转化为底物。
J Biol Chem. 1994 Jul 29;269(30):19559-64.

引用本文的文献

1
High-throughput amino acid-level characterization of the interactions of plasminogen activator inhibitor-1 with variably divergent proteases.纤溶酶原激活物抑制剂-1与可变差异蛋白酶相互作用的高通量氨基酸水平表征
Protein Sci. 2025 Apr;34(4):e70088. doi: 10.1002/pro.70088.
2
The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation.C1 酯酶抑制剂与 C1s 的米氏复合体的晶体结构揭示了补体调控的新见解。
J Immunol. 2024 Sep 1;213(5):718-729. doi: 10.4049/jimmunol.2400194.
3
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.
抗凝血丝氨酸蛋白酶抑制剂:止血和血栓形成的内源性调节因子。
Front Cardiovasc Med. 2022 May 3;9:878199. doi: 10.3389/fcvm.2022.878199. eCollection 2022.
4
Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape.深突变扫描纤溶酶原激活物抑制剂-1 的功能图谱。
Sci Rep. 2021 Sep 22;11(1):18827. doi: 10.1038/s41598-021-97871-7.
5
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.心血管疾病中靶向纤溶酶原激活物抑制剂-1:纤溶酶原激活物抑制剂-1功能及抑制作用的结构见解
Front Cardiovasc Med. 2020 Dec 22;7:622473. doi: 10.3389/fcvm.2020.622473. eCollection 2020.
6
Panax notoginsenoside Rb1 Restores the Neurotrophic Imbalance Following Photothrombotic Stroke in Rats.三七总皂苷 Rb1 可恢复光血栓性脑卒中大鼠的神经营养失衡。
Neurotox Res. 2019 Oct;36(3):441-451. doi: 10.1007/s12640-019-00058-2. Epub 2019 May 25.
7
Reactive centre loop dynamics and serpin specificity.反应中心环动力学与丝氨酸蛋白酶抑制剂特异性。
Sci Rep. 2019 Mar 7;9(1):3870. doi: 10.1038/s41598-019-40432-w.
8
Slow fusion pore expansion creates a unique reaction chamber for co-packaged cargo.缓慢的融合孔扩张为共包封货物创造了一个独特的反应室。
J Gen Physiol. 2017 Oct 2;149(10):921-934. doi: 10.1085/jgp.201711842. Epub 2017 Sep 7.
9
Neuroserpin Differentiates Between Forms of Tissue Type Plasminogen Activator via pH Dependent Deacylation.神经丝氨酸蛋白酶抑制剂通过pH依赖性脱酰作用区分组织型纤溶酶原激活剂的不同形式。
Front Cell Neurosci. 2016 Jun 15;10:154. doi: 10.3389/fncel.2016.00154. eCollection 2016.
10
Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1.沿着反应中心环的单个荧光探针揭示了纤溶酶原激活物抑制剂-1潜伏转变过程中的位点特异性变化。
Protein Sci. 2016 Feb;25(2):487-98. doi: 10.1002/pro.2839. Epub 2015 Nov 25.